Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 38, 2006 - Issue 8
Submit an article Journal homepage
79
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

HTLV-2 infection in injection drug users in King County, Washington

Joseph R. Zunt From the Departments of Neurology and Medicine (Infectious Diseases),; Center for AIDS and STD, University of Washington School of Medicine,Correspondence[email protected]
,
Ken Tapia Center for AIDS and STD, University of Washington School of Medicine,
,
Hanne Thiede Public Health-Seattle and King County, Seattle, WA
,
Rong Lee Public Health-Seattle and King County, Seattle, WA
&
Holly Hagan National Development and Research Institutes, New York, USA
Pages 654-663 | Received 09 Nov 2005, Published online: 08 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kerstin Malm, Bengt Ekermo, Kristina Hillgren, Sven Britton, Hans Fredlund & Sören Andersson. (2012) Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden. Scandinavian Journal of Infectious Diseases 44:11, pages 852-859.
Read now

Articles from other publishers (9)

Adele Caterino-de-Araujo. (2023) Sex, Age, and Risk Group Variations among Individuals Infected with HIV, HTLV-1, and HTLV-2: Review of Data Records (1983–2017) from a Public Health Laboratory in São Paulo, Brazil. Sexes 4:4, pages 638-655.
Crossref
Lucas Pinheiro Correa, Fatyene da Costa Farias, Katarine Antonia dos Santos Barile, Maurício Koury Palmeira & Carlos Eduardo de Melo Amaral. (2023) Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil. Brazilian Journal of Microbiology.
Crossref
Felicidade Mota Pereira, Pablo Ivan Pereira Ramos, Monique Lirio, Ajax Mercês Atta, Isabela Silva de Oliveira, Fabio Carneiro Vosqui Nascimento, Marcelo Costa Silva, Bernardo Galvão-Castro & Maria Fernanda Rios Grassi. (2021) Evaluation of the Inflammatory Cytokines and IL-10 Network in Individuals Co-infected With Human T-Cell Lymphotropic Virus and Hepatitis C Virus (HTLV/HCV). Frontiers in Microbiology 12.
Crossref
Robert Paulino-Ramirez, Leandro Tapia, Carlos Ruiz-Matuk, Rebecca Charow, Henna Budhwani & Jean-Pierre Routy. (2019) Human T-cell lymphotropic virus 1/2 and human immunodeficiency virus antibodies identification among transactional sex workers and drug users in the Dominican Republic. Transactions of The Royal Society of Tropical Medicine and Hygiene.
Crossref
Lucy Platt, Silvia Minozzi, Jennifer Reed, Peter Vickerman, Holly Hagan, Clare French, Ashly Jordan, Louisa Degenhardt, Vivian Hope, Sharon Hutchinson, Lisa Maher, Norah Palmateer, Avril Taylor, Julie Bruneau & Matthew Hickman. (2017) Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database of Systematic Reviews 2017:9.
Crossref
Ma'an VTFasola FAEgesie OJMa'an DN. (2016) Seroprevalence and risk factors for human T cell lymphotropic viruses types 1 and 2 among blood donors in Jos, Nigeria. International Journal of Blood Transfusion and Immunohematology 6:2, pages 1-7.
Crossref
Erika Castro & Elena Roger. (2016) Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs. World Journal of Virology 5:2, pages 68.
Crossref
Leonardo Ramos GalettoVagner Ricardo LungeJorge Umberto BériaDaniela Cardoso TietzmannAirton Tetelbom SteinDaniel Simon. (2014) Short Communication: Prevalence and Risk Factors for Human T Cell Lymphotropic Virus Infection in Southern Brazilian HIV-Positive Patients. AIDS Research and Human Retroviruses 30:9, pages 907-911.
Crossref
Fabianna Bahia, Vinicius Novais, Jennifer Evans, Chloe Le Marchand, Eduardo Netto, Kimberly Page & Carlos Brites. (2011) The Impact of Human T-Cell Lymphotropic Virus I Infection on Clinical and Immunologic Outcomes in Patients Coinfected With HIV and Hepatitis C Virus. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:Supplement 3, pages S202-S207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.